molecules-logo

Journal Browser

Journal Browser

Nanodelivery Systems: Current Status and Translational Opportunities

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Nanochemistry".

Deadline for manuscript submissions: closed (15 October 2022) | Viewed by 343

Special Issue Editors

Department of Pharmaceutical Sciences, Wegmans School of Pharmacy, St. John Fisher College, 3690 East Avenue, Room # RCW107, Rochester, NY 14618, USA
Interests: liposomes; targeted drug delivery; niosomes; nanoformulations; PLGA nanoparticles; micelles; thermoreversible gel; controlled release; ocular drug delivery
Special Issues, Collections and Topics in MDPI journals
Taneja College of Pharmacy, USF Health, University of South Florida, Tampa, FL 33612, USA
Interests: nanodrug delivery; thermoreversible gel; ocular drug delivery; age-related macular degeneration; corneal delivery; polymeric nanoparticles; polymeric micelles; biomaterials

Special Issue Information

Dear Colleagues,

A nanomedicine-based therapeutic approach has the potential to effectively deliver therapeutic agents to the site of action. Nanotechnology offers various advantages, including sustained delivery, targeted delivery to specific cells or tissue, reduced side effects, and improved delivery for lipophilic/macro molecules. Nanoscale delivery systems with sustained releasing properties are mainly advantageous in enhancing already existing therapeutic agents for improving efficacy and patient compliance. The emergence of various nanotechnology-based delivery systems, such as nanoparticles, niosomes, liposomes, in situ gel, dendrimers, and micelles, has the potential to treat various diseases. Future potential applications of nanodrug delivery in ophthalmology can improve routine drug delivery systems and clinical treatments. This Special Issue welcomes works on all topics regarding nanodelivery of a drug/gene and translational opportunities. This will serve as a unique platform for the current research on nanodelivery of therapeutic agents, including their design, development, characterization, and translational applications.

Dr. Priyanka Bhatt
Dr. Vijaykumar B. Sutariya
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nano drug delivery
  • nanoformulations
  • targeted delivery
  • sustained release
  • biomaterial
  • nanoparticles
  • in situ gel
  • nanocarriers
  • liposomes
  • niosomes
  • micelles

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop